Medical Distribution Stocks
4 US-listed medical distribution companies above our tradable floor ($5 and $1 million a day), largest first, with each one's stage, price and valuation after the close.
4
companies
3 (75%)
in a Stage 2 uptrend
+13.0%
3-month return, weighted by size
0 · 1 · 0
in Stage 1 · 3 · 4
Filter them in the screener →All Health Care stocks →Industry rotation →
Every medical distribution stock we cover
| Stock | Stage | Close | Day | 3 months | From high | RS | P/E | Yield | Market cap |
|---|---|---|---|---|---|---|---|---|---|
| MCKMcKesson | Stage 2, wk 9 | $994.58 | +1.4% | +20.4% | -3.5% | 72 | 27.1 | 0.37% | $116B |
| CORCencora | Stage 2, wk 5 | $330.84 | +0.1% | +7.5% | -11.2% | 54 | 25.1 | 0.71% | $63.1B |
| CAHCardinal Health | Stage 2, wk 2 | $250.48 | -0.2% | +6.6% | -2.9% | 87 | 35.4 | 0.80% | $58.0B |
| HSICHenry Schein | Stage 3, wk 3 | $84.88 | -1.8% | -1.9% | -6.6% | 79 | 25.1 | — | $9.5B |
Medical Distribution Stocks: quick answers
How many medical distribution stocks are in an uptrend?
As of Oct 30, 2026, 3 of the 4 US-listed medical distribution stocks we cover are in Stage 2, the uptrend phase, including McKesson (MCK), Cencora (COR) and Cardinal Health (CAH).
What is the largest medical distribution stock?
McKesson (MCK), with a market value of $116B. It closed at $994.58 on Oct 30, 2026, in Stage 2.
Which medical distribution stocks are near their 52-week high?
As of Oct 30, 2026, 2 are within 5% of a 52-week high: McKesson (MCK) and Cardinal Health (CAH).
End-of-day data for common stocks and ADRs on the NYSE, Nasdaq and NYSE American, computed after each US close and dated to the trading session.